zauderer mesothelioma

Web results
A new standard for malignant pleural mesothelioma - The Lancet
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)01311-2/abstractby MG Zauderer - ‎2016 - ‎Cited by 7 - ‎Related articlesDec 21, 2015 - Marjorie G Zauderer ... Mesothelioma is an asbestos-related malignancy that begins in the pleural lining of the lung, pericardium, peritoneum, ...
Vinorelbine and gemcitabine as second- or third-line therapy for ...
https://www.ncbi.nlm.nih.gov/pubmed/24690410


by MG Zauderer - ‎2014 - ‎Cited by 46 - ‎Related articlesMar 14, 2014 - Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleuralmesothelioma. Zauderer MG(1), Kass SL(2), Woo K(3), Sima ...
A new standard for malignant pleural mesothelioma - NCBI - NIH
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464401/by MG Zauderer - ‎2016 - ‎Cited by 7 - ‎Related articlesDec 21, 2015 - Marjorie G. Zauderer, MD, MS, FACP ... pleural mesothelioma in the MesotheliomaAvastin Cisplatin Pemetrexed Study (MAPS): a randomised, ...
Patterns of comorbidity, treatment, resource utilization, and referral in ...
ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.8554by MG Zauderer - ‎2017May 20, 2017 - Marjorie Glass Zauderer ... Background: Malignant pleural mesothelioma (MPM) is a rare but aggressive cancer, which may be challenging to ...
Marjorie G. Zauderer | Memorial Sloan Kettering Cancer Center
https://www.mskcc.org/cancer-care/doctors/marjorie-zauderer



I am a medical oncologist specializing in the care of patients with lung cancer and mesothelioma. My practice aims to provide personalized care to patients ...

Board of Directors | Marjorie G. Zauderer, MD, MS, FACP ...
www.curemeso.org/.../Mesothelioma_Research__Science_Advisory_Board__Marjorie...



Dr. Marjorie G. Zauderer, MD, MS, FACP is co-director of the MSK Mesothelioma Program and Assistant Attending on the Thoracic Oncology Service in the ...
NEWS: Encouraging data released for EZH2 inhibitor study for ...
blog.curemeso.org › News


Jul 10, 2018 - This study enrolled 61 BAP1 loss-of-function mesothelioma patients ... Dr. Zauderer, medical oncologist and co-director of the Mesothelioma ...
A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 ...
clincancerres.aacrjournals.org/content/early/2017/11/02/1078-0432.CCR-17-2169by MG Zauderer - ‎2017 - ‎Cited by 7 - ‎Related articlesMarjorie G. Zauderer, Anne S. Tsao, Tao Dao, Katherine S. Panageas, ... (PFS) among patients with malignant pleural mesothelioma (MPM) receiving the WT1 ...
Novel Therapies in Phase II and III Trials for Malignant Pleural ...
www.jnccn.org/content/10/1/42.fullby MG Zauderer - ‎2012 - ‎Cited by 24 - ‎Related articlesMalignant pleural mesothelioma (MPM) is a rare malignancy of the pleura that ..... Dr. Zauderer has disclosed that she has no financial interests, arrangements, ...
Mesothelioma | Cycle for Survival
https://www.cycleforsurvival.org/mesothelioma-1


Mesothelioma is a cancer that affects the lungs, specifically a membrane surrounding the ... Drs. Andreas Rimner, Marjorie Zauderer, and Valerie Rusch have ...




Searches related to zauderer mesothelioma

memorial sloan kettering doctors directory
memorial sloan kettering long island locations
memorial sloan kettering in connecticut
mskcc directory

memorial sloan kettering google maps
205 east 64th street new york ny 10022
memorial sloan kettering cancer center logo
msk logo

Page navigation
1 2 3 4 5 6 7 8 9 10 Next